Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Grundmann

Showing results (61-70 of 127) with videos related to

Pageof 13
Sort By:
Human Psychopharmacology|July 27, 2019
Distinct kratom user populations across the United States: A regional analysis based on an online surveyJessica A Nicewonder, Amy F Buros, Charles A Veltri, et al.
Substance Use & Misuse|July 27, 2019
Effects of Kratom (<i>Mitragyna Speciosa</i> Korth.) Use in Regular UsersDarshan Singh, Suresh Narayanan, Oliver Grundmann, et al.
Addiction (Abingdon, England)|June 28, 2018
The therapeutic potential of kratomOliver Grundmann, Paula N Brown, Jack Henningfield, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 22, 2023
Biomarkers and mechanisms associated with cancer-induced cardiac cachexia: A systematic reviewLisa Bagnall, Oliver Grundmann, Marilyn G Teolis, et al.
Journal of Psychoactive Drugs|March 1, 2025
Prevalence and Use Patterns of Kratom (<i>Mitragyna speciosa</i> Korth.) in a US Nationally Representative SampleOliver Grundmann, MeShell Green, Erin Berthold, et al.
Frontiers in Pharmacology|June 18, 2024
Kratom safety and toxicology in the public health context: research needs to better inform regulationJack E Henningfield, Oliver Grundmann, Marilyn A Huestis, et al.
Frontiers in Public Health|June 14, 2024
Kratom as a potential substance use disorder harm reduction agentMeShell Green, Nina Vadiei, Charles A Veltri, et al.
Nutrients|November 27, 2021
Insufficient Vitamin C Levels among Adults in the United States: Results from the NHANES Surveys, 2003-2006Jennifer Crook, Ann Horgas, Saun-Joo Yoon, et al.
Frontiers in Pharmacology|February 25, 2021
The Burden of the Serious and Difficult-to-Treat Infections and a New Antibiotic Available: CefiderocolYasaman Taheri, Nataša Joković, Jelena Vitorović, et al.
The American Journal of Drug and Alcohol Abuse|January 30, 2025
At least four groups of kratom consumers in the United States: latent-class analysis of motivations for kratom useKatherine Hill, Jeffrey M Rogers, Oliver Grundmann, et al.
Pageof 13

Showing results (61-70 of 127) with videos related to

Sort By:
Pageof 13
Human Psychopharmacology|July 27, 2019
Distinct kratom user populations across the United States: A regional analysis based on an online surveyJessica A Nicewonder, Amy F Buros, Charles A Veltri, et al.
Substance Use & Misuse|July 27, 2019
Effects of Kratom (<i>Mitragyna Speciosa</i> Korth.) Use in Regular UsersDarshan Singh, Suresh Narayanan, Oliver Grundmann, et al.
Addiction (Abingdon, England)|June 28, 2018
The therapeutic potential of kratomOliver Grundmann, Paula N Brown, Jack Henningfield, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 22, 2023
Biomarkers and mechanisms associated with cancer-induced cardiac cachexia: A systematic reviewLisa Bagnall, Oliver Grundmann, Marilyn G Teolis, et al.
Journal of Psychoactive Drugs|March 1, 2025
Prevalence and Use Patterns of Kratom (<i>Mitragyna speciosa</i> Korth.) in a US Nationally Representative SampleOliver Grundmann, MeShell Green, Erin Berthold, et al.
Frontiers in Pharmacology|June 18, 2024
Kratom safety and toxicology in the public health context: research needs to better inform regulationJack E Henningfield, Oliver Grundmann, Marilyn A Huestis, et al.
Frontiers in Public Health|June 14, 2024
Kratom as a potential substance use disorder harm reduction agentMeShell Green, Nina Vadiei, Charles A Veltri, et al.
Nutrients|November 27, 2021
Insufficient Vitamin C Levels among Adults in the United States: Results from the NHANES Surveys, 2003-2006Jennifer Crook, Ann Horgas, Saun-Joo Yoon, et al.
Frontiers in Pharmacology|February 25, 2021
The Burden of the Serious and Difficult-to-Treat Infections and a New Antibiotic Available: CefiderocolYasaman Taheri, Nataša Joković, Jelena Vitorović, et al.
The American Journal of Drug and Alcohol Abuse|January 30, 2025
At least four groups of kratom consumers in the United States: latent-class analysis of motivations for kratom useKatherine Hill, Jeffrey M Rogers, Oliver Grundmann, et al.
Pageof 13